This dominance reflects the current treatment paradigm where GLP-1 medications are primarily positioned and reimbursed for obesity management based on BMI criteria rather than cardiovascular risk reduction
This hepatic enzyme converts UA to allantoin, and its absence results in serum UA concentrations relatively elevated by, typically, an order of magnitude
Weve got, you know, 6
[1] [3] Seek urgent medical attention if you experience: Severe or persistent abdominal pain, especially if radiating to your back Repeated vomiting preventing fluid intake Signs of dehydration (dark urine, dizziness, reduced urination) Contact your GP or prescriber routinely if you experience: Ongoing digestive symptoms affecting your quality of life Significant, persistent weight regain Concerns about resuming treatment If you experience any suspected side effects, you can report them via the MHRA Yellow Card scheme
pharmacies, and personalized lifestyle support
Stopping them does not mean losing progress